SPS
JAZZ icon

Susquehanna Portfolio Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Sell
19,169
-24,108
-56% -$5.28M 0.07% 297
2026
Q1 		$8.18M Hold
43,277
– – 0.12% 215
2025
Q4 		$7.36M Buy
43,277
+340
+0.8% +$52.1K 0.11% 238
2025
Q3 		$5.66M Buy
42,937
+14,008
+48% +$1.68M 0.09% 296
2025
Q2 		$3.07M Buy
+28,929
New +$3.14M 0.07% 288

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Susquehanna Portfolio Strategies's JAZZ Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q2 2026, selling an estimated $5.28M and leaving 19,169 shares worth $4.62M. The position accounts for 0.07% of the portfolio, ranked #297.

Susquehanna Portfolio Strategies first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.18M in Q1 2026. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Susquehanna Portfolio Strategies held 19,169 shares of Jazz Pharmaceuticals worth $4.62M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 24,108 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.28M.
  • Jazz Pharmaceuticals made up 0.07% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #297 holding.
  • Susquehanna Portfolio Strategies first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Jazz Pharmaceuticals position peaked at $8.18M in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.